IMCT-18 PD-1 INHIBITORS FOR RECURENT HIGH GRADE GLIOMA (HGG)

類似資料

• IMCT-09 WT1 PEPTIDE VACCINATION FOR GLIOMAS; SURVIVALS, BIOMARKERS AND RESPONSE ASSESSMENT
  著者:: Hashimoto, Naoya, 等
  出版事項: (2015)
• GENO-16 TO CATALOG THE MOLECULAR ALTERATIONS IDENTIFIED DURING GENOMIC ANALYSIS OF GLIOMAS AND THE UTILITY IN PERSONALIZING THERAPY
  著者:: Haggiagi, Aya, 等
  出版事項: (2015)
• IMCT-16 SERIAL EVALUATION OF LYMPHOCYTE SUBSETS IN PATIENTS WITH NEWLY DIAGNOSED HIGH GRADE GLIOMAS TREATED WITH STANDARD RADIATION AND TEMOZOLOMIDE
  著者:: Campian, Jian, 等
  出版事項: (2015)
• IMCT-14 AN UPDATE ON IPILIMUMAB AND BEVACIZUMAB IN GLIOBLASTOMA
  著者:: Mulholland, Paul, 等
  出版事項: (2015)
• IMCT-02 PHASE II MULTICENTER STUDY OF GENE MEDIATED CYTOTOXIC IMMUNOTHERAPY AS ADJUVANT TO SURGICAL RESECTION FOR NEWLY DIAGNOSED MALIGNANT GLIOMA
  著者:: Chiocca, E. Antonio, 等
  出版事項: (2015)